Gene expression profiles of drug-metabolizing enzymes and transporters with an overexpression of hepatocyte growth factor
- PMID: 17241389
- DOI: 10.1111/j.1478-3231.2006.01384.x
Gene expression profiles of drug-metabolizing enzymes and transporters with an overexpression of hepatocyte growth factor
Erratum in
- Liver Int. 2007 Jun;27(5):733. Horigichi, Norio [corrected to Horiguchi, Norio]
Abstract
Background: It is important to elucidate the precise mechanism of drug metabolism during hepatic regeneration. Although cytochromes P450 (CYPs) are well known to be down-regulated in growth-stimulated cells, the overall gene expression profile of drug metabolizing enzymes are still not fully understood during hepatic regeneration. In this study, we investigated the gene expression profiles of such enzymes with an overexpression of hepatocyte growth factor (HGF).
Methods: Gene expression profiles were obtained using the Affymetrix MOE430A GeneChip oligonucleotide microarray by comparing HGF transgenic mice and wild-type mice.
Results: HGF produced a general decrease in mice with the expression of CYP isoforms such as Cyp1a2, Cyp2b10, Cyp2c, Cyp2d9, Cyp3a11, Cyp4a10, and Cyp7a1. Some isoforms of alcohol dehydrogenase, aldehyde dehydrogenase, and carboxylesterase also decreased. In the phase II enzymes, some isoforms of glutathione S-transferase and UDP-glucuronosyl transferase showed a reduced expression, although the sulfotransferase did not. In phase III transporters, some organic anion transporter and organic cation transporters were down-regulated. Among the nuclear receptors that are known to regulate the drug-metabolizing enzymes, small heterodimer partner and constitutive androstane receptor were down-regulated with an HGF overexpression. The protein level and enzymatic activity of Cyp2c decreased with an HGF overexpression. We furthermore investigated the inducibility of Cyp2b10 with xenobiotic inducers. Although the basal expression of Cyp2b10 was repressed, the inducibility was not abolished with the HGF overexpression.
Conclusions: HGF down-regulated not only CYPs but also some drug-metabolizing enzymes, transporters, and nuclear receptors. We thus have to take in our mind the low basal expression of drug metabolizing enzymes, when treating patients with a regenerative liver state.
Similar articles
-
The effect of Nrf2 knockout on the constitutive expression of drug metabolizing enzymes and transporters in C57Bl/6 mice livers.Toxicol In Vitro. 2011 Jun;25(4):785-95. doi: 10.1016/j.tiv.2011.01.014. Epub 2011 Jan 31. Toxicol In Vitro. 2011. PMID: 21281708
-
Ligand dependent hepatic gene expression profiles of nuclear receptors CAR and PXR.Toxicol Lett. 2012 Aug 3;212(3):288-97. doi: 10.1016/j.toxlet.2012.06.001. Epub 2012 Jun 12. Toxicol Lett. 2012. PMID: 22698814
-
Microarray analysis on Phase II drug metabolizing enzymes expression in pregnant rats after treatment with pregnenolone-16alpha-carbonitrile or phenobarbital.Exp Mol Pathol. 2005 Dec;79(3):272-7. doi: 10.1016/j.yexmp.2005.08.002. Epub 2005 Oct 11. Exp Mol Pathol. 2005. PMID: 16223480
-
Animal models of xenobiotic receptors in drug metabolism and diseases.Methods Enzymol. 2005;400:598-618. doi: 10.1016/S0076-6879(05)00034-0. Methods Enzymol. 2005. PMID: 16399373 Review.
-
Expression and inducibility of P450 enzymes during liver ontogeny.Microsc Res Tech. 1997 Dec 1;39(5):424-35. doi: 10.1002/(SICI)1097-0029(19971201)39:5<424::AID-JEMT5>3.0.CO;2-G. Microsc Res Tech. 1997. PMID: 9408909 Review.
Cited by
-
Significance and mechanism of CYP7a1 gene regulation during the acute phase of liver regeneration.Mol Endocrinol. 2009 Feb;23(2):137-45. doi: 10.1210/me.2008-0198. Epub 2008 Dec 4. Mol Endocrinol. 2009. PMID: 19056864 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources